Prospera Financial Services Inc Argenx Se Transaction History

Prospera Financial Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$269.58 - $378.88 $211,350 - $297,041	-784 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$254.45 - $351.06 $199,488 - $275,231	784 New	784 $247,000
Q3 2020 Nov 04, 2020	SELL	$215.51 - $272.51 $229,087 - $289,678	-1,063 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$127.44 - $232.72 $135,468 - $247,381	1,063 New	1,063 $239,000
Q1 2020 May 15, 2020	SELL	$108.83 - $165.23 $190,887 - $289,813	-1,754 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$106.59 - $164.21 $186,958 - $288,024	1,754 New	1,754 $282,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.